Institutional analyst consensus ratings for AVITA Medical predominantly lean toward a Strong Buy or moderate buy recommendation. Covering analysts highlight the company's expanding market penetration, resolution of past reimbursement headwinds, and growing adoption across major burn and trauma centers. A small minority of analysts maintain a hold rating, advising caution until the firm officially hits its anticipated quarterly profitability targets.